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A B S T R A C T
The retrospective investigation was done about relationships between diabetes and cranial nerve lesions (CNL) on the
sample of hospitalized neurological patients in Clinical Hospital Dubrava (CHD) in 6 yrs. period (2001–2006). The goal
was to expand the cognition about CNL as a complication of diabetes, to investigate possibility of better therapy models as
well as to investigate the prevention possibilities.The results show that CNL are significantly more present by the diabetic
patients vrs. the other hospitalized neurological patients. The main risk factors for CNL development are the duration of
diabetes, patient’s age and diabetes per se. No significant differences between masculine and feminine patients were reg-
istered nor by diabetics neither by other patients. For CNL are also not from signifficant importance the successfully
treatment of diabetes, as well as type of antidiabetic and other medication. This investigation can not confirm the suspi-
cion that some of antidiabetic medicaments are responsible for CNL due to their neurotoxic side effects.
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Introduction
Diabetes is the most common endocrine disease. To-
day’s lifestyle, associated diseases, as well as longer life
expectancy of the population, will surely contribute to in-
creasing prevalence of diabetes, and increased incidence
of diabetic complications.
Review of available literature, particularly since 1990
until now, it is evident that a lot of attention was devoted
to peripheral polyneuropathy, as one of the complica-
tions, but we do not find many papers on the topic of
mononeuropathies, and especially among them do not
find much about the central mononeuropathy.
Recent research on the topic craniopathy is retrospec-
tive, with the aim of getting to know all the risk factors
and early detection of lesions. It may be observed that
the most affected by the frequency are n. abducens, n.
oculomotorius, n. trochlearis, and finally facial nerve.
Other brain nerves are rare or sporadically affected1–3.
A correlation was seen with age, sex, comorbidity, dia-
betes control, the method of treatment. It is not found
the correlation between any of these parameters and the
incidence of central neuropathy6,7,12.
In several studies etiological factor has been sought
for the occurrence of craniopathies, and in them was
found that over 50% of all patients have neuropathy as a
complication of diabetes, also a total of 18 different possi-
ble other causes of neuropathy, one of which is the most
common chronic inflammatory demyelination. Among
the other causes were mentioned aneurysms, tumors,
trauma, vascular lesions1,3–5,8,10,13.
Materials and Methods
A retrospective study were performed on a sample of
7229 patients, representing all hospitalized patients at
the Department of Neurology, Clinical Hospital Dubrava
during the period of six years (2001–2006).
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From the sample (7229) we have extracted patients
with diabetes besides the neurological symptoms, which
were the reason of hospitalization (310).
Also, we are especially singled out from above 7229,
all persons who had CNL (70) and divided them into two
groups, diabetics (29) and nondiabetics (41).
Observed group was named a group of patients who
suffer from diabetes and have CNL (29). We used two
control groups, the first group consisted from patients
who suffer from diabetes and have CNL (310), a second
group consisted from patients who have CNL and no dia-
betes (41).
A statistical form was created for all patients, which
included: full name of patient, medical history identifica-
tion, gender, year of birth, reason for admission, dis-
charge diagnosis, habits (drinking coffee, alcohol, ciga-
rette smoking), medication, and the essental information
about diabetes (family burden of diabetes, duration of di-
abetes, age when the therapy was introduced, treatment
of diabetes on admission, diabetes treatment at dis-
charge, blood glucose levels on admission, specific com-
plications of diabetes), lesion of cranial nerves, the out-
come of therapy of craniopaties during hospitalization.
If the treatment of diabetes differed at discharge com-
pared to treatment on admission, it was considered as
treatment failures.
Habit of enjoying coffee, alcohol and cigarettes were
processed qualitatively. The persons who have practiced
stated every day for more than three years, were rated
positively.
Statistics
Study was made with descriptive statistics.
All qualitative data are presented in tables in the ab-
solute number and percentage. Differences of quantita-
tive variables between two groups were tested with a
nonparametric test for independent samples (Mann-
Whitney U-test). Quantitative data are presented in me-
dian and corresponding range. The differences of quali-
tative variables between two groups were tested by
 -square test with Yates correction. Effect of some pa-
rameters on the occurrence of cranial nerve lesions was
tested by logistic regression.
Results were considered statistically significant if p<
0.05.
Data analysis was done on the PC statistical program
Statistica 6.0.
Results
Total patients with CNL was 70. N. facialis was af-
fected in 31 patients (44.3%), n. abducens in 27 (38.6%),
n. oculomotorius in 17 (24.3%), N. glossopharingeus in 3
patients (4.3%) (Table 1).
In patients with diabetes n. facialis was affected in 14
(48.3%), n. oculomotorius them 10 (34.5%), and n. abdu-
cens them in 8 (27.6%) (Table 2).
In this group we didn’t have patients with lesions of
n. glossopharingeus and n. trigeminus. We are particu-
larly singled out patients with retinopathy and patients
with diabetes. In patients who have retinopathy n. abdu-
cens was affected in 3 patients, n. oculomotorius in 2,
and n. facialis in 1 patient (Table 3).
In the group of patients with CNL suffering and not
suffering from diabetes, we found a statistically signifi-
cant difference in age. Patients suffering from diabetes
and have CNL on average are older than patients with-
out diabetes and have CNL (p=0.0038) (Table 4).
We did not find statistically significant differences by
gender (p=0.5449), the therapeutic outcome of cranio-
pathy (p=0.6558), the drugs that patients were taking
beside the antidiabetics (p=0.0563). In the group of pa-
tients with diabetes with and without CNL we found a
statistically significant difference in duration of diabetes.
In patients suffering from diabetes and have CNL on
averageduration of diabetes lasted longer (p=0.0001)
(Table 5).
In the same group of patients we found a statistically
significant difference according to the specific complica-
tions of diabetes. In patients who have CNL statistically
significantly higher is prevalence of retinopathy (p=
0.0078) (Table 6).
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TABLE 1
DISTRIBUTION OF LESIONS IN HOSPITALIZED NEUROLOGICAL
PATIENTS WHO ARE SUFFERING AND NOT SUFFERING FROM
DIABETES, ACCORDING TO A PARTICULAR CRANIAL NERVE
INVOLVEMENT
Affected nerve N %
N. facialis 31 44.3
N. abducens 27 38.6
N. oculomotorius 17 24.3
N. glosofaringeus 3 4.3
N. trigeminus 1 1.4
TABLE 2
DISTRIBUTION OF THE INVOLVEMENT OF SOME CRANIAL
NERVES IN PATIENTS WITH DIABETES
Affected nerve N %
N. facialis 14 48.3
N. oculomotorius 10 34.5
N. abducens 8 27.6
TABLE 3





Total Nr. of patients 6
We did not find statistically significant differences by
gender (p=0.9155), by age (p=0.3787), according to dia-
betes treatment (p=0.7771), according to the outcome of
treatment of diabetes (p=0.8630), the medication pa-
tients were taking beside antidiabetic (p=0.2312). The
influence of certain parameters on the occurrence of cra-
nial nerve lesions was tested by logistic regression. It was
found that the risk factors for the occurrence of CNL are
diabetes (OR=1.812, p=0.0001), duration of diabetes
(OR=1.125, p=0.0001), retinopathy (OR=3.590, p=
0.0129) (Table 7).
Discussion
Patients who are involved in the research groups were
selected among the 7229 patients who were hospitalized
during six years in the Department of Neurology Hospi-
tal Dubrava in Zagreb within the period 2001 to 2006.
Without exception, all documents are reviewed for all pa-
tients who were hospitalized during this period. The
study was retrograde. The main reason for hospitaliza-
tion of patients on admission was neurological problems.
Frequently, patients were admitted in hospital as emer-
gencies, which means that they developed acute neuro-
logical problems. If it is a fact that one patient was admit-
ted several times, and entered in the studied group, they
take into account the data of his last stay in the ward.
The most common reason for admission to the Neurology
Department was a stroke.
By the patients who have had CNL, the lesion was
usually the only reason for admission to a neurological
hospital, in 95% of cases in patients who had as well as
those who didn’t have diabetes, and among them there
was no statistically significant differencies.
Among 7229 medical histories of hospitalized pa-
tients, 380 patients were allocated and divided into three
groups. The first consisted of all patients who had at
least one lesion of cranial nerve (70), a second group
gathered all patients who had diabetes (310). These two
groups were called control. The third, study group, com-
prised patients who suffered from both diabetes and
CNL (29). Mutual comparisons were performed with
each of the observed control group for better understand-
ing the relationships between diabetes and CNL.
It was found that CNL is significantly present more
frequently in people with diabetes than other neurologi-
cal population that does not suffer from diabetes, making
clear that diabetes is a significant risk factor for appear-
ing of CNL. In fact in more than 95% of cases this was
the only neurological outburst in hospitalized patients
and the only neurological complications in patients with
diabetes and other population without diabetes, consid-
ering that the frequency of occurrence CNL by groups
and size of groups of diabetics and nondiabetics clearly
indicates that the CNL is significantly more frequent by
diabetic patients vs. the nondiabetic patients. In the ear-
lier published studies we found similar result2,6,17.
In our study we didn’t find significant differences be-
tween the two groups by gender. So there is no statisti-
cally significant differences in gender representation
among diabetic and nondiabetic patients with CNL, as
well as by the diabetic patients regardless whether or not
they have CNL.
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TABLE 4








Median (span) 66.0 (32–86) 50.0 (16–79) p=0.0038
TABLE 5
THE DISTRIBUTION OF DIABETIC PATIENTS WITH AND WITHOUT CNL THE DURATION OF DIABETES
With CNL N=29 Without CNL N=310
Statisticaly signifficance
of difference
Hystory of DM (yrs) 12.0 (8–25) 10.0 (0–35) p=0.0001
TABLE 6
THE DISTRIBUTION OF DIABETIC PATIENTS WITH AND WITHOUT CNL USUALLY ACCOMPANIED BY COMPLICATIONS OF DIABETES
complications OF DM With CNL N=29 Without CNL N=310
Statisticaly signifficance
of difference
Retinopathy 6 (20.7%) 21 (6.8%) p=0.0078
Polyneuropathy 6 (20.7%) 39 (12.6%) p=0.2637
Nephropathy 2 (6.9%) 20 (6.5%) p=0.7633
Similar results were found in other studies of correla-
tion between CNL and diabetes6.
If we compare each group with CNL depending on
whether or not they have diabetes, then it is evident that
examinees with diabetes and CNL were significantly
older than those without diabetes complicated with CNL.
Simultaneously among diabetic patients with and with-
out CNL, there is no significant differences by age. The
result is a little bit surprising. We expected that this com-
plication, CNL, like most other health complications
occures much earlier in people who suffer from diabetes
than other neurological patients, and they would conse-
quently be a younger population. However, the results
are interpreted in other etiological factors that cause
CNL by the nondiabetic population, which occur in the
population of middle and younger age1,10.
There was a question in the survey outcome of CNL
therapy in diabetic and nondiabetic individuals. It was
believed that treatment of CNL in diabetic patients must
be much more obstinate than in nondiabetics. However,
the results showed no statistically significant difference
whether CNL occurred among the other risk factors or
diabetes. During hospitalisation there wasn’t no one sin-
gle case with deterioration of the disease, and the extent
of improvement vrs. no change situation has no statisti-
cally significant differences. Such a result is not found in
previous works which deal with this issue.
If one looks at the people who suffer from diabetes,
with and without CNL it is evident that there is a statis-
tically significant difference regard to duration of diabe-
tes. Specifically, those diabetes patients who were hos-
pitaized because of the acute CNL, had significantly
longer average of diabetic medical history than those
with diabetes who were hospitalized due to other neuro-
logical reasons, and no CNL.
A similar result is found by other researchers, al-
though they have based their papers on different, in our
opinion incomplete groups of patients with CNL, partly
unclear and inconsistently selected, which is not the case
in our study14. Specifically, among them were observed
only those patients who had the disorder eye movements.
Because they belonged to »hormonal population« they
were not compared with CNL among patients with no di-
abetes, as we have done since our respondents were »a
neurological hospital population«.
There was a question whether the treatment of diabe-
tes has an impact on the CNL occurrence, due to suspi-
cion that the neurologic complications can be prevented
by the early introduction of insulin therapy in combina-
tion with or without oral antidiabetics. There is also dis-
senting opinion that some antidiabetics are neurotoxic,
increasing the risk of occurrence of neurological compli-
cations in diabetes. This primarily refers to insulin.
We note here that this was a major stimulus for our
research: to investigate whether insulin in addition to his
»irreplaceability« in the treatment of diabetes is also
neurotoxic with specific effects on cranial nerves, and
then beyond. However, research has clearly shown that
CNL, as well as neurological complications in diabetes, is
not dependent on the method of treatment of diabetes.
No statistically significant differences between treat-
ments for diabetes in diabetic patients with and without
CNL6.
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TABLE 7
RISK FACTORS FOR THE OCCURRENCE OF CRANIAL NERVE LESIONS
OR
95 % Confidence limits
p
Lover Upper
Diabetes 1.812 11.10 29.59 0.0001
Gender 1.035 0.48 2.22 0.9297
Age 0.966 0.93 1.00 0.0818
Antihypertensives 0.520 0.21 1.28 0.1552
Anticoagulants 0.827 0.23 2.92 0.7674
Psychotropic medications 0.420 0.05 3.25 0.4049
Other medications 0.582 0.17 2.04 0.3973
Irregular medication 4.606 0.87 24.32 0.0718
Duration of diabetes 1.125 1.06 1.19 0.0001
Diet 1.091 0.24 4.95 0.9099
Oral hypoglycemics 0.478 0,27 1.07 0.0734
Insulin 0.773 0.28 2.13 0.6176
Diabetic Retinopathy 3.590 1.31 9.81 0.0129
Polyneuropathy 1.813 0.69 4.75 0.2250
Nephropathy 1.074 0.24 4.86 0.9259
Successful therapy of DM 1.154 0.54 2.49 0.7142
Also, in this study we could not confirm the hypothe-
sis that there is any difference among patients with dia-
betes with and without CNL depending on the success of
glycemia control and treating diabetes3,6,7,12.
According to the above, we can not claim that a major
risk factor for CNL is exclusively poor control of diabe-
tes, although we can not exclude its importance because
it violates the very nature of diabetes and previous the-
ses. Specifically, poor regulation sometimes and often is
almost equally represented on average in all of our pa-
tients with diabetes, so its not noticed a significant influ-
ence on neurological complications.
By poor regulation of glycaemia, in fact diabetes, it
would be interesting considering the CNL to see which
type of acute complications is more risky, whether hypo-
glycaemic, hyperglycamic or combined crisis. In our stu-
dy we have had the intention to explore the area, but the
data we found in the medical histories didn’t enable this.
Research oft his type would lead to interesting results,
and probably should be prospective.
The result of poor control of diabetes were always
hyperglycemia, and in no any case hypoglycemia.
If we compare the other most common complications
that occur in diabetes such as retinopathy, nephropathy
and polyneuropathy, it is clear that CNL is associated
with retinopathy. The retinopathy are significantly more
likely occurs in diabetics with CNL than in those without
CNL15,16,18.
The obtained result is ascribed to the fact that the ret-
ina of the peripheral nervous system, but functionally
and anatomically very close to the central nervous sys-
tem that belongs to the cranial nerve, n opticus. As such,
the retina is also susceptible to damage in people with di-
abetes.
Also, in people with diabetes is the question of whe-
ther certain chronic therapy poses a particular risk fac-
tor for the occurrence of CNL. That is, whether some of
the chronic drug therapy is »especially neurotoxic« in di-
abetes if it is not among individuals without diabetes.
Our results could not confirm this assumption, name-
ly there was no statistically significant differences be-
tween individualss with diabetes with and without CNL
depending on the drugs that are taken as a chronic ther-
apy.
It is interesting to note that among CNL the most
common affected is n. facialis, and at least n. trigeminus.
Among the others the most common are oculomotoric
nerves. This result is consistent with results of other
researches1–3.
Conclusion
The results show that diabetes is a significant risk
factor for the occurrence of cranial nerve lesions. The
probability of a patient who suffers from diabetes to get
CNL is 18 times higher than if he does not suffer from di-
abetes.
The statistically significant difference was find among
diabetic patients with and without CNL due to the dura-
tion of diabetes. Logistic regression was found that with
each year of diabetes duration increases the probability
of CNL occurrence by 12.5%.
Among the patients who are suffering and not suffer-
ing from diabetes and have CNL there was a statistically
significant difference in age. Diabetic patients that suffer
also from CNL are on average older than nondiabetic pa-
tients with CNL.
There was a statistically significant correlation be-
tween CNL and retinopathy. Diabetic patients with reti-
nopathy have a 3 and a half times more probability to get
CNL than patients with diabetes and no retinopathy.
Gender is not a risk factor for CNL appereance for di-
abetic as well as nondiabetic patients.
There was no statistically significant differences in
the occurrence CNL among patients in the way of treat-
ment of diabetes, which waste the hypothesis that the
antidiabetics are neurotoxic.
It was not found that the success of treatment is a sig-
nificant factor in the emerging CNL, even though we
booked it because our approach to the concept of success-
ful treatment of diabetes was limited and framed by a
possibilities of a retrospective study.
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LEZIJE KRANIJALNIH @IVACA U OSOBA OBOLJELIH OD DIJABETESA
S A @ E T A K
Ra|eno je retrospektivno istra`ivanje povezanosti dijabetesa i LK@ (lezije kranijalnih `ivaca) na uzorku hospita-
liziranih neurolo{kih pacijenata u KB Dubrava tijekom 6 godina (2001–2006. god.). Cilj istra`ivanja je bio da se pro{iri
spoznaja o LK@ kao komplikacije dijabetesa, istra`i mogu}nost uspje{nijeg lije~enja, te istra`iti mogu}nost prevencije
iste. Rezultati ukazuju da se LK@ zna~ajno ~e{}e doga|a kod osoba koje boluju od dijabetesa nego kod ostalih neuro-
lo{kih bolesnika koji su zahtjevali hospitalizaciju. Glavni rizi~ni ~imbenik za nastanak LK@ je du`ina trajanja dija-
betesa, dob bolesnika s dijabetesom, te sam dijabetes. Spol nije rizi~ni ~imbenik za nastanak LK@, kako kod bolesnika s
dijabetesom tako niti kod bolesnika bez dijabetesa. Zna~ajnim se, po nastanak LK@, nije pokazala niti uspje{nost lije~e-
nja dijabetesa, vrsta antidijabetika, kao niti vrsta druge kroni~ne terapije koju su bolesnici uzimali pored antidijabe-
tika. Ovo istra`ivanje ne potvr|uje sumnju da su neki antidijabetici neurotoksi~ni u smislu LK@.
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